Lars Rydén
-
- Diabetes Treatment and Management 56
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 32
- Diabetes, Cardiovascular Risks, and Lipoproteins 29
- Diabetes Management and Research 24
-
- Cardiovascular Function and Risk Factors 35
- Acute Myocardial Infarction Research 18
-
- Cardiac Imaging and Diagnostics 14
- Internal Medicine top 5%
- Surgery top 5%
-
- Metabolism, Diabetes, and Cancer 35
- Co-authors
- Hans WedelKlas MalmbergSuad EfendićAnna NorhammarAnders WaldenströmJohan HerlitzPeter NicolLennart Welin
- Cited by
- Endocrinology, Diabetes and MetabolismCardiology and Cardiovascular MedicineRadiology, Nuclear Medicine and Imaging
- Journals
- Diabetes and Vascular Disease Research (18 papers)Diabetes Care (16 papers)European Heart Journal (15 papers)
- Partner nations
- SwedenUnited KingdomGermany
In The Last Decade
Lars Rydén
156 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Endocrinology, Diabetes and Metabolism 3.9k
- Cardiology and Cardiovascular Medicine 3.2k
- Radiology, Nuclear Medicine and Imaging 541
- Internal Medicine 88
- Surgery 981
Countries citing papers authored by Lars Rydén
This map shows the geographic impact of Lars Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Rydén more than expected).
Fields of papers citing papers by Lars Rydén
This network shows the impact of papers produced by Lars Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Rydén. The network helps show where Lars Rydén may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lars Rydén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 3 | |
| 4 | 2021 | 48 | |
| 5 | 2021 | 9 | |
| 6 | 2020 | 11 | |
| 7 | 2020 | 2 | |
| 8 | 2016 | 5 | |
| 9 | 2015 | 4 | |
| 10 | 2015 | 12 | |
| 11 | 2014 | 32 | |
| 12 | 2013 | 39 | |
| 13 | 2011 | 102 | |
| 14 | 2010 | 10 | |
| 15 | 2009 | 58 | |
| 16 | 2008 | 59 | |
| 17 | 2007 | 34 | |
| 18 | 2004 | 237 | |
| 19 | 2001 | 374 | |
| 20 | 2000 | 2 |
About Lars Rydén
Lars Rydén is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Periodontics, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 161 papers that have together received 6.7k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (56 papers), Cardiovascular Function and Risk Factors (35 papers), Metabolism, Diabetes, and Cancer (35 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (32 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (29 papers), Diabetes Management and Research (24 papers), Acute Myocardial Infarction Research (18 papers) and Cardiac Imaging and Diagnostics (14 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.9k citations), Cardiology and Cardiovascular Medicine (3.2k citations), Radiology, Nuclear Medicine and Imaging (541 citations), Internal Medicine (88 citations) and Surgery (981 citations). Lars Rydén has collaborated with scholars based in Sweden, United Kingdom and Germany. Frequent co-authors include Hans Wedel, Klas Malmberg, Suad Efendić, Anna Norhammar, Anders Waldenström, Johan Herlitz, Peter Nicol, Lennart Welin, Linda Mellbin and John Öhrvik. Their work appears in journals such as Diabetes and Vascular Disease Research, Diabetes Care, European Heart Journal, European Journal of Preventive Cardiology and Cardiovascular Diabetology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.